Strong Won Cuts APR's Operating Profit for First Time in 7 Quarters, Though Revenue Hits Another Record High
Predicted impact: Medium
Operating profit falls for first time in seven quarters despite record revenue.
APR에이피알
278470 · KOSPI · ₩278470 · 에이피알
₩261,000▼ ₩21,500 (7.61%)End-of-day · Oct 30, 2026 · End-of-day prices.
APR Surpasses ₩2T in Cumulative Q3 Sales; Overseas Sales Share at 94%
Predicted impact: Low
Cumulative Q3 sales above 2 trillion won already reported in earlier items and preliminary filing.
APR takes off on North America and Europe... Q3 operating profit ₩160.6B
Predicted impact: Medium
Q3 operating profit ₩160.6B, up 68.9%, already reported in earlier items.
APR Q3 revenue ₩773.1B, 'record high'… soaring in US and Europe
Predicted impact: Medium
Q3 record revenue ₩773.1B already disclosed in preliminary earnings and covered; no new figures.
APR's cumulative Q3 revenue tops ₩2T… surpasses last year's full-year results (roundup)
Predicted impact: Medium
Cumulative revenue beats last year; already reported in earlier APR earnings news.
APR sets new annual revenue record in just three quarters, cumulative revenue passes ₩2T
High impactPredicted impact: High
Annual revenue record in three quarters; large results far above last year, lowered as repeat.
APR Q3 operating profit ₩160.6B, up 68.9% from a year earlier
Predicted impact: Medium
Q3 operating profit up 68.9% already reported via preliminary earnings filing in last 14 days
[Today's market schedule] APR, Hyundai Autoever, LG CNS and others
Predicted impact: Low
Market schedule listing; no company-specific event described.
APR goes beyond cosmetics to make dermatology medical devices, aiming to become a comprehensive skincare company
Predicted impact: Low
Entry into dermatology devices is strategic but no size or revenue impact disclosed.
APR: Finding Your Skin Type in a Pink-Hued Lounge? Even Londoners Can't Resist!
Predicted impact: Low
Consumer feature on cosmetics; no financial or disclosure event in the headline.
After Hearing Explanation, Exchange Announces Plan to Designate APR as Unfaithful Disclosure Entity; Full Probe into Leak of Earnings Information
High impactPredicted impact: High
Exchange plans unfaithful-disclosure designation and earnings-leak probe; prior notice already filed, so lowered one level.
APR: Strong demand persists despite exchange-rate pressure; target price ₩550,000
Predicted impact: Low
Broker keeps strong demand view; target price set but no new disclosure of size.
APR: Combined use of devices and cosmetics increases skin radiance improvement effect
Predicted impact: Low
Costco US store expansion for Medicube already reported in the last 14 days.
K-Beauty becomes benchmark in UK cosmetics market; APR's local sales grow triple digits
Predicted impact: Low
UK sales growth story follows recent US retail expansion coverage; no size in won given.
APR Publishes Research in International Journal on Synergy Between Home Beauty Devices and Cosmetics
Predicted impact: Low
Academic publication on product synergy; routine and immaterial to earnings.
APR's 'Medicube' Enters Costco in the U.S.
Predicted impact: Low
Costco listing already reported repeatedly; store expansion is modest in impact.
APR expands US retail presence as Medicube hits Costco shelves
Predicted impact: Low
Costco retail listing for Medicube; same expansion already reported multiple times in last 14 days, size not disclosed.
APR’s Medicube Enters 400 Costco Stores, Expanding U.S. Retail Reach
Predicted impact: Low
Costco listing extends prior retail wins like Walmart and Ulta, no size given.
APR expands in North America's K-beauty market, entering Costco after Walmart
Predicted impact: Low
Costco store listing in 400 US stores; no size disclosed and repeated in earlier items.
After Ulta, Target and Walmart, Now Costco Too: APR Lands in 400 US Stores
Predicted impact: Low
Costco 400-store US entry was already reported in several recent items.
Also known as: APR / 에이피알 / 278470 / KRX:278470
Source: KRX statistical information